Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00028327
What this trial is testing

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 250
Early research (Phase 1)Study completedNCT00000893
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 103
Post-approval studies (Phase 4)Study completedNCT01420055
What this trial is testing

Fingolimod -Response According to Coping - Evaluation

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Novartis Pharmaceuticals 189
Large-scale testing (Phase 3)Study completedNCT02675426
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone

Who this might be right for
Rheumatoid Arthritis
AbbVie 661
Post-approval studies (Phase 4)Study completedNCT00979706
What this trial is testing

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

Who this might be right for
HIV
Juan A. Arnaiz 22
Not applicableStudy completedNCT03445234
What this trial is testing

Blueberries, Bananas, Exercise Recovery

Who this might be right for
Inflammatory ResponseMetabolic DisturbanceImmune Suppression
Appalachian State University 60
Large-scale testing (Phase 3)Study completedNCT00503425
What this trial is testing

MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 215
Testing effectiveness (Phase 2)Study completedNCT01851707
What this trial is testing

Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

Who this might be right for
Rheumatoid Arthritis
SecuraBio 322
Not applicableLooking for participantsNCT07267000
What this trial is testing

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER

Who this might be right for
Non-Small Cell Lung CancerExercise TrainingImmunotherapy+1 more
Medical University of Graz 50
Not applicableStudy completedNCT04418206
What this trial is testing

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19

Who this might be right for
Covid 19
Centre Hospitalier Universitaire de Nice 950
Testing effectiveness (Phase 2)Study completedNCT00174746
What this trial is testing

Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

Who this might be right for
Asthma
Sanofi 1,145
Not applicableStudy completedNCT03053713
What this trial is testing

The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of British Columbia 28
Large-scale testing (Phase 3)Study completedNCT01521923
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 359
Not applicableStudy completedNCT03159273
What this trial is testing

Nitrate Supplementation During Final Examination Stress

Who this might be right for
Airway Disease
Southern Methodist University 76
Not applicableStudy completedNCT01617005
What this trial is testing

Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 50
Large-scale testing (Phase 3)Study completedNCT00001561
What this trial is testing

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Who this might be right for
Graft vs Host DiseaseMultiple Myeloma
National Cancer Institute (NCI) 30
Not applicableNot Yet RecruitingNCT06839014
What this trial is testing

Exercise Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCC
Our Lady of the Lake Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02141997
What this trial is testing

Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 222
Testing effectiveness (Phase 2)Study completedNCT00766597
What this trial is testing

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 9
Large-scale testing (Phase 3)Study completedNCT02889796
What this trial is testing

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 1,759
Next Page